Hulse William Frank IV's Form 4 filing
Mimedx Group, Inc. (MDXG) · filed Mar 14, 2025
- Accession no.
- 0001376339-25-000031
- Filed
- Mar 14, 2025
- Trade date
- Mar 13, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $430.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hulse William Frank IVCIK 0001796044 | Officer (General Counsel and CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | Common Stock | SSaleDisposed | −34,230 | $7.89 | −$270,074.7 | 460,544 | Direct | |
| Mar 13, 2025 | Common Stock | SSaleDisposed | −20,366 | $7.89 | −$160,687.74 | 440,178 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.